Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 1
1958 1
1984 1
1986 1
1988 1
1993 1
1994 3
1996 1
1997 1
1998 2
1999 2
2000 6
2001 2
2002 3
2003 3
2004 7
2005 9
2006 13
2007 6
2008 10
2009 11
2010 9
2011 10
2012 14
2013 18
2014 18
2015 12
2016 14
2017 14
2018 15
2019 14
2020 16
2021 13
2022 20
2023 20
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

262 results

Results by year

Filters applied: . Clear all
Page 1
Association between changes in carbohydrate intake and long term weight changes: prospective cohort study.
Wan Y, Tobias DK, Dennis KK, Guasch-Ferré M, Sun Q, Rimm EB, Hu FB, Ludwig DS, Devinsky O, Willett WC. Wan Y, et al. BMJ. 2023 Sep 27;382:e073939. doi: 10.1136/bmj-2022-073939. BMJ. 2023. PMID: 37758268 Free PMC article.
Among men and women, increases in glycemic index and glycemic load were positively associated with weight gain. For example, a 100 g/day increase in starch or added sugar was associated with 1.5 kg and 0.9 kg greater weight gain over four years, respectively, wherea …
Among men and women, increases in glycemic index and glycemic load were positively associated with weight gain. For example, a 100 g/ …
Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes.
Nair ATN, Wesolowska-Andersen A, Brorsson C, Rajendrakumar AL, Hapca S, Gan S, Dawed AY, Donnelly LA, McCrimmon R, Doney ASF, Palmer CNA, Mohan V, Anjana RM, Hattersley AT, Dennis JM, Pearson ER. Nair ATN, et al. Nat Med. 2022 May;28(5):982-988. doi: 10.1038/s41591-022-01790-7. Epub 2022 May 9. Nat Med. 2022. PMID: 35534565
In this study, we applied a reverse graph embedding method to routinely collected data from 23,137 Scottish patients with newly diagnosed diabetes to visualize this heterogeneity and used partitioned diabetes polygenic risk scores to gain insight into the underlying biolog …
In this study, we applied a reverse graph embedding method to routinely collected data from 23,137 Scottish patients with newly diagnosed di …
Zonisamide: Antipsychotic Weight Gain.
Generali JA, Cada DJ. Generali JA, et al. Hosp Pharm. 2015 Mar;50(3):199-201. doi: 10.1310/hpj5003-199. Hosp Pharm. 2015. PMID: 26405308 Free PMC article.
Topiramate: antipsychotic-induced weight gain.
Generali JA, Cada DJ. Generali JA, et al. Hosp Pharm. 2014 Apr;49(4):345-7. doi: 10.1310/hpj4904-345. Hosp Pharm. 2014. PMID: 24958940 Free PMC article.
The gain paradox.
Berg H. Berg H. Prog Biophys Mol Biol. 2009 Sep-Oct;100(1-3):2-3. doi: 10.1016/j.pbiomolbio.2009.06.001. Epub 2009 Jun 9. Prog Biophys Mol Biol. 2009. PMID: 19520104 Free PMC article.
A small change in receptor occupancy induces a large change in kinase activity. This gain is generated by allosteric interactions between receptors, which are arranged in clusters. The idea that such amplification might occur was advanced by Dennis Bray in 1998, and …
A small change in receptor occupancy induces a large change in kinase activity. This gain is generated by allosteric interactions bet …
Sex differences in weight gain during medication-based treatment for opioid use disorder: A meta-analysis and retrospective analysis of clinical trial data.
Manza P, Kroll D, McPherson KL, Johnson A, Dennis E, Hu L, Tai B, Volkow ND. Manza P, et al. Drug Alcohol Depend. 2022 Sep 1;238:109575. doi: 10.1016/j.drugalcdep.2022.109575. Epub 2022 Jul 16. Drug Alcohol Depend. 2022. PMID: 35868182 Free PMC article.
BACKGROUND: Side effects of medications for opioid use disorder (MOUD) such as weight gain contribute to their stigma. Substantial evidence suggests that women have a more severe side effect profile to MOUD than men, and concerns about weight gain during treatment a …
BACKGROUND: Side effects of medications for opioid use disorder (MOUD) such as weight gain contribute to their stigma. Substantial ev …
Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial.
Kymes SM, Oden NL, VanVeldhuisen PC, Scott IU, Ip MS, Blodi BA, King J; SCORE2 Investigator Group. Kymes SM, et al. JAMA Ophthalmol. 2023 Jun 1;141(6):554-561. doi: 10.1001/jamaophthalmol.2023.1463. JAMA Ophthalmol. 2023. PMID: 37166820
When coupled with the lack of clinical superiority over bevacizumab (ie, patients treated with bevacizumab had a gain over aflibercept in visual acuity letter score of 4 in the treated eye and 2 in the fellow eye), these results demonstrate that first-line treatment with b …
When coupled with the lack of clinical superiority over bevacizumab (ie, patients treated with bevacizumab had a gain over aflibercep …
Controlled Cortical Impact Model.
Osier ND, Korpon JR, Dixon CE. Osier ND, et al. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 16. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 16. PMID: 26269887 Free Books & Documents. Review.
., 1972; Nilsson, Ponten, and Voigt, 1977; Ommaya, Geller, and Parsons, 1971; Ommaya and Gennarelli, 1974; Rinder and Olsson, 1968; Sullivan et al., 1976; Denny-Brown and Russell, 1941; Kramer, 1896; Cannon, 1901; Parkinson, West, and Pathiraja, 1978). ...Briefly, CCI cons …
., 1972; Nilsson, Ponten, and Voigt, 1977; Ommaya, Geller, and Parsons, 1971; Ommaya and Gennarelli, 1974; Rinder and Olsson, 1968; Sullivan …
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial.
Noureddin M, Khan S, Portell F, Jorkasky D, Dennis J, Khan O, Johansson L, Johansson E, Sanyal AJ. Noureddin M, et al. Lancet Gastroenterol Hepatol. 2023 Dec;8(12):1094-1105. doi: 10.1016/S2468-1253(23)00198-X. Epub 2023 Oct 5. Lancet Gastroenterol Hepatol. 2023. PMID: 37806314 Clinical Trial.
The primary endpoint was the relative change in liver fat content from baseline to day 61, as assessed by MRI-PDFF, and was analysed in the full analysis set (FAS), which comprised all participants who were randomly assigned, received at least one dose of treatment, and had less …
The primary endpoint was the relative change in liver fat content from baseline to day 61, as assessed by MRI-PDFF, and was analysed in the …
25th Annual Computational Neuroscience Meeting: CNS-2016.
Sharpee TO, Destexhe A, Kawato M, Sekulić V, Skinner FK, Wójcik DK, Chintaluri C, Cserpán D, Somogyvári Z, Kim JK, Kilpatrick ZP, Bennett MR, Josić K, Elices I, Arroyo D, Levi R, Rodriguez FB, Varona P, Hwang E, Kim B, Han HB, Kim T, McKenna JT, Brown RE, McCarley RW, Choi JH, Rankin J, Popp PO, Rinzel J, Tabas A, Rupp A, Balaguer-Ballester E, Maturana MI, Grayden DB, Cloherty SL, Kameneva T, Ibbotson MR, Meffin H, Koren V, Lochmann T, Dragoi V, Obermayer K, Psarrou M, Schilstra M, Davey N, Torben-Nielsen B, Steuber V, Ju H, Yu J, Hines ML, Chen L, Yu Y, Kim J, Leahy W, Shlizerman E, Birgiolas J, Gerkin RC, Crook SM, Viriyopase A, Memmesheimer RM, Gielen S, Dabaghian Y, DeVito J, Perotti L, Kim AJ, Fenk LM, Cheng C, Maimon G, Zhao C, Widmer Y, Sprecher S, Senn W, Halnes G, Mäki-Marttunen T, Keller D, Pettersen KH, Andreassen OA, Einevoll GT, Yamada Y, Steyn-Ross ML, Alistair Steyn-Ross D, Mejias JF, Murray JD, Kennedy H, Wang XJ, Kruscha A, Grewe J, Benda J, Lindner B, Badel L, Ohta K, Tsuchimoto Y, Kazama H, Kahng B, Tam ND, Pollonini L, Zouridakis G, Soh J, Kim D, Yoo M, Palmer SE, Culmone V, Bojak I, Ferrario A, Merrison-Hort R, Borisyuk R, Kim CS, Tezuka T, Joo P, Rho YA, Burt… See abstract for full author list ➔ Sharpee TO, et al. BMC Neurosci. 2016 Aug 18;17 Suppl 1(Suppl 1):54. doi: 10.1186/s12868-016-0283-6. BMC Neurosci. 2016. PMID: 27534393 Free PMC article.
Ibbotson, Hamish Meffin O6 Noise correlations in V4 area correlate with behavioral performance in visual discrimination task Veronika Koren, Timm Lochmann, Valentin Dragoi, Klaus Obermayer O7 Input-location dependent gain modulation in cerebellar nucleus neurons Maria Psar …
Ibbotson, Hamish Meffin O6 Noise correlations in V4 area correlate with behavioral performance in visual discrimination task Veronika Koren, …
262 results